{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In the presence of coronary artery stenosis , 3 - min periods of intracoronary ISO infusion ( 10 ng / kg / min ) increased heart rate and maximal rate of left ventricular pressure rise , which resulted in a decrease in percentage segmental shortening and ST - segment elevation of the epicardial electrocardiogram .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| coronary artery stenosis |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| coronary artery stenosis |"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In the presence of coronary artery stenosis , 3 - min periods of intracoronary ISO infusion ( 10 ng / kg / min ) increased heart rate and maximal rate of left ventricular pressure rise , which resulted in a decrease in percentage segmental shortening and ST - segment elevation of the epicardial electrocardiogram .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| ISO (Isosorbide mononitrate) |\n\nIn the presence of coronary artery stenosis, 3-min periods of intracoronary ISO infusion (10 ng / kg / min) increased heart rate and maximal rate of left ventricular pressure rise, which resulted in a decrease in percentage segmental shortening and ST-segment elevation of the epicardial electrocardiogram.\n\nThere is only one chemical entity mentioned in the paragraph, which is Isosorbide mononitrate (ISO)."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Isosorbide mononitrate (ISO) |\n\nIn the presence of coronary artery stenosis, 3-min periods of intracoronary ISO infusion (10 ng / kg / min) increased heart rate and maximal rate of left ventricular pressure rise, which resulted in a decrease in percentage segmental shortening and ST-segment elevation of the epicardial electrocardiogram.\n\nIsosorbide mononitrate (ISO) is the only chemical entity mentioned in the paragraph. The other entities mentioned, such as coronary artery stenosis, heart rate, maximal rate of left ventricular pressure rise, percentage segmental shortening, and ST-segment elevation, are not chemical entities but rather physiological or diagnostic terms."}
  ]
}